PlK3CA is implicated as an oncogene in ovarian cancer

Nature Genetics

Volumn 21, Issue 1, 1999, Pages 99-102

  Shayesteh, Laleh ^a   Lu, Yiling ^b   Kuo, Wen Lin ^a   Baldocchi, Russell ^a   Godfrey, Tony ^a   Collins, Colin ^a,c   Pinkel, Daniel ^a,c   Powell, Bethan ^a   Mills, Gordon B ^b   Gray, Joe W ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CANCER MORTALITY; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME 3Q; FEMALE; HUMAN; HUMAN CELL; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; CHROMOSOME 3; DRUG ANTAGONISM; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; OVARY TUMOR;

2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; MORPHOLINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CHROMONES; CHROMOSOMES, HUMAN, PAIR 3; ENZYME INHIBITORS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MORPHOLINES; ONCOGENES; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032590011     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/5042     Document Type: Article

References (34)

1. Phyllis, A., Tony, T. & Sherry, B. Cancer statistics. CA Cancer J. Clin. 45, 8-30 (1995) .
2. Iwabuchi, H. et al. Genetic analysis of benign, low-grade, and high-grade ovarian tumors Cancer Res. 55, 6172-6180 (1995).
3. Arnold, N. et al. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16, 46-54 (1996).
4. Sonoda, G. et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20, 320-328 (1997).
5. Knuutila, S. et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol. 152, 1107-1123 (1998).
6. Downward, J. Has signalling and apoptosis. Curr. Opin. Genet. Dev. 8, 49-54 (1998).
7. Klippel, A. et al. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol. 18, 5699-5711 (1998).
8. Frevert, E.U. & Kahn, B.B. Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol. Cell. Biol. 17, 190-198 (1997).
9. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P.H. & Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. IMBO J. 16, 2783-2793 (1997).
10. Kennedy, S.G. et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701-713 (1997).
11. Chang, H.W. et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276, 1848-1850 (1997).
12. Jimenez, C. et al. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J. 17, 743-753 (1998).
13. Meili, R., Cron, P., Hemmings, B.A. & Ballmer-Hofer, K. Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a phosphatidylinositol 3-kinase-dependent mechanism. Oncogene 16, 903-907 (1998).
14. Kapeller, R. & Cantley, L. Phosphatidylinositol 3-kinase. Bioessays 16, 565-576 (1994).
15. Marte, B.M. & Downward, J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22, 355-358 (1997).
16. Cheng, J. et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl Acad. Sci. USA 89, 9267-9271 (1992).
17. Liu, A.X. et al. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Res. 58, 2973-2977 (1998).
18. Hass-Kogan, D. et al. PKB/akt activity is elevated in glioblastoma cells due to mutation of PTEN/MMAC1. Curr. Biol. B, 1195-1198 (1998).
19. Rodriguez-Viciana, P., Warne, P., Vanhaesebroeck, B., Waterfield, M. & Downward, J. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15, 2442-2451 (1996).
20. Kauffmann-Zeh, A. et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385, 544-548 (1997).
21. Shi, Y. et al. Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res. 55, 1982-1988 (1995).
22. Kulik, G., Klippel, A. & Weber, M.J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17, 1595-606 (1997).
23. Schildkraut J., Bastos, E. & Berchuck, A. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J. Natl Cancer Inst. 89, 932-938 (1997).
24. Nigro, J.M., Aldape, K.D., Hess, S.M. & Tlsty, T.D. Cellular adhesion regulates p53 protein levels in primary human keratinocytes. Cancer Res. 57, 3635-3639 (1997).
25. Auersperg, N., Siemens, C.H. & Myrdal, S.E. Human ovarian surface epithelium in primary culture. In Vitro 20, 743-755 (1984).
26. Hurteau, J. et al. Transforming growth factor-β inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer 74, 93-99 (1994).
27. Kallioniemi, O.-P. et al. C-erbB-2 oncogene amplification in breast cancer detected by fluorescence in situ hybridization. Proc. Natl Acad. Sci. USA 89, 5321-5325 (1992).
28. Sternberg, N., Ruether, J. & DeRiel, K. Generation of a 50,000-member human DNA library with an average DNA insert size of 75-100 kbp in a bacteriophage P1 cloning vector. New Biol. 2, 151-162 (1990).
29. Collins, C. et al. Positional cloning of ZNF217 and NABCl: genes amplified at 20q13 and overexpressed in breast carcinoma. Proc. Natl Acad. Sci. USA 95, 8703-8708 (1998).
30. Gibson, S. et al. Efficient CD28 signaling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK and SRC family tyrosine kinase LCK. Biochem. J. 330, 1123-1128 (1998).
31. Hinson, D. & Webher, R. Miniaturization of BCA protein assay. Biotechniques 6, 14-19 (1998).
32. Truitt, K., Hicks, C. & Imboden, J. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J. Exp. Med. 179, 1071-1076 (1994).
33. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 16, 55-63 (1983).
34. Gorczyca, W., Melamed, M.R. & Darzynkiewicz, Z. Analysis of apoptosis by flow cytometry. Methods Mol. Biol. 91, 217-38 (1998).